Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Frequently asked questions
What sector does Dyadic International Inc (DYAI) operate in?
Dyadic International Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Dyadic International Inc (DYAI) current stock price?
As of the latest data, Dyadic International Inc stock price is $0.41, with a previous close of $0.42. Dyadic International Inc lost -$0.01 in the last trading session, representing a -2.4% loss.
What is Dyadic International Inc (DYAI) current market capitalization?
Dyadic International Inc market cap is approximately 16.27 million.
What is Dyadic International Inc (DYAI) Earnings Per Share (EPS)?
The trailing EPS is -$0.21, and the forward EPS is $0.02.
What is Dyadic International Inc (DYAI) EBITDA?
Dyadic International Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.01 million.
Does Dyadic International Inc (DYAI) pay dividends?
No. Dyadic International Inc does not pay a dividend.
How did Dyadic International Inc (DYAI) perform in its most recent earnings report?
In the last report (June 30, 2026), Dyadic International Inc posted an EPS surprise of -100% and a revenue surprise of -1.62%.
What is Dyadic International Inc (DYAI) beta (volatility) score?
Dyadic International Inc has a beta of 0.962, meaning its volatility is roughly in line with the market.
